nodes	percent_of_prediction	percent_of_DWPC	metapath
Darifenacin—CYP3A4—Chenodeoxycholic acid—primary biliary cirrhosis	0.188	0.664	CbGbCtD
Darifenacin—CYP3A4—Colchicine—primary biliary cirrhosis	0.0949	0.336	CbGbCtD
Darifenacin—Flu symptoms—Chenodeoxycholic acid—primary biliary cirrhosis	0.0492	0.0698	CcSEcCtD
Darifenacin—Flu symptoms—Ursodeoxycholic acid—primary biliary cirrhosis	0.0492	0.0698	CcSEcCtD
Darifenacin—Accidental injury—Ursodeoxycholic acid—primary biliary cirrhosis	0.00965	0.0137	CcSEcCtD
Darifenacin—Accidental injury—Chenodeoxycholic acid—primary biliary cirrhosis	0.00965	0.0137	CcSEcCtD
Darifenacin—Bladder pain—Colchicine—primary biliary cirrhosis	0.00859	0.0122	CcSEcCtD
Darifenacin—Vaginal inflammation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00854	0.0121	CcSEcCtD
Darifenacin—Vaginal inflammation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00854	0.0121	CcSEcCtD
Darifenacin—Vaginal infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00806	0.0114	CcSEcCtD
Darifenacin—Vaginal infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00806	0.0114	CcSEcCtD
Darifenacin—Bladder pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00772	0.011	CcSEcCtD
Darifenacin—Bladder pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00772	0.011	CcSEcCtD
Darifenacin—Abnormal vision—Ursodeoxycholic acid—primary biliary cirrhosis	0.00745	0.0106	CcSEcCtD
Darifenacin—Abnormal vision—Chenodeoxycholic acid—primary biliary cirrhosis	0.00745	0.0106	CcSEcCtD
Darifenacin—Injury—Chenodeoxycholic acid—primary biliary cirrhosis	0.00674	0.00956	CcSEcCtD
Darifenacin—Injury—Ursodeoxycholic acid—primary biliary cirrhosis	0.00674	0.00956	CcSEcCtD
Darifenacin—Cerebrovascular accident—Ursodeoxycholic acid—primary biliary cirrhosis	0.00633	0.00897	CcSEcCtD
Darifenacin—Cerebrovascular accident—Chenodeoxycholic acid—primary biliary cirrhosis	0.00633	0.00897	CcSEcCtD
Darifenacin—Aspartate aminotransferase increased—Colchicine—primary biliary cirrhosis	0.00621	0.00881	CcSEcCtD
Darifenacin—Alanine aminotransferase increased—Colchicine—primary biliary cirrhosis	0.00608	0.00863	CcSEcCtD
Darifenacin—Face oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.00598	0.00849	CcSEcCtD
Darifenacin—Face oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.00598	0.00849	CcSEcCtD
Darifenacin—Breast disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.0056	0.00794	CcSEcCtD
Darifenacin—Breast disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.0056	0.00794	CcSEcCtD
Darifenacin—Aspartate aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00558	0.00792	CcSEcCtD
Darifenacin—Aspartate aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00558	0.00792	CcSEcCtD
Darifenacin—Alanine aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00547	0.00775	CcSEcCtD
Darifenacin—Alanine aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00547	0.00775	CcSEcCtD
Darifenacin—Influenza—Ursodeoxycholic acid—primary biliary cirrhosis	0.00536	0.0076	CcSEcCtD
Darifenacin—Influenza—Chenodeoxycholic acid—primary biliary cirrhosis	0.00536	0.0076	CcSEcCtD
Darifenacin—Stomatitis—Colchicine—primary biliary cirrhosis	0.00518	0.00735	CcSEcCtD
Darifenacin—Bronchitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00515	0.00731	CcSEcCtD
Darifenacin—Bronchitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00515	0.00731	CcSEcCtD
Darifenacin—Weight increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00488	0.00692	CcSEcCtD
Darifenacin—Weight increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00488	0.00692	CcSEcCtD
Darifenacin—Infestation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00478	0.00678	CcSEcCtD
Darifenacin—Infestation NOS—Chenodeoxycholic acid—primary biliary cirrhosis	0.00478	0.00678	CcSEcCtD
Darifenacin—Infestation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00478	0.00678	CcSEcCtD
Darifenacin—Infestation NOS—Ursodeoxycholic acid—primary biliary cirrhosis	0.00478	0.00678	CcSEcCtD
Darifenacin—Urinary tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00464	0.00659	CcSEcCtD
Darifenacin—Urinary tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00464	0.00659	CcSEcCtD
Darifenacin—Sweating—Ursodeoxycholic acid—primary biliary cirrhosis	0.00458	0.0065	CcSEcCtD
Darifenacin—Sweating—Chenodeoxycholic acid—primary biliary cirrhosis	0.00458	0.0065	CcSEcCtD
Darifenacin—Sinusitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00448	0.00636	CcSEcCtD
Darifenacin—Sinusitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00448	0.00636	CcSEcCtD
Darifenacin—Eye disorder—Colchicine—primary biliary cirrhosis	0.00446	0.00633	CcSEcCtD
Darifenacin—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.0043	0.0061	CcSEcCtD
Darifenacin—Rhinitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.0043	0.0061	CcSEcCtD
Darifenacin—Rhinitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.0043	0.0061	CcSEcCtD
Darifenacin—Pharyngitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00426	0.00604	CcSEcCtD
Darifenacin—Pharyngitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00426	0.00604	CcSEcCtD
Darifenacin—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00423	0.00601	CcSEcCtD
Darifenacin—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00423	0.00601	CcSEcCtD
Darifenacin—Oedema peripheral—Chenodeoxycholic acid—primary biliary cirrhosis	0.00422	0.00599	CcSEcCtD
Darifenacin—Oedema peripheral—Ursodeoxycholic acid—primary biliary cirrhosis	0.00422	0.00599	CcSEcCtD
Darifenacin—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.0042	0.00596	CcSEcCtD
Darifenacin—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.0042	0.00596	CcSEcCtD
Darifenacin—Visual impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.00413	0.00586	CcSEcCtD
Darifenacin—Visual impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.00413	0.00586	CcSEcCtD
Darifenacin—Eye disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00401	0.00568	CcSEcCtD
Darifenacin—Eye disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00401	0.00568	CcSEcCtD
Darifenacin—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.00389	0.00552	CcSEcCtD
Darifenacin—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.00389	0.00552	CcSEcCtD
Darifenacin—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00386	0.00548	CcSEcCtD
Darifenacin—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00386	0.00548	CcSEcCtD
Darifenacin—Angioedema—Colchicine—primary biliary cirrhosis	0.0038	0.00538	CcSEcCtD
Darifenacin—Flatulence—Ursodeoxycholic acid—primary biliary cirrhosis	0.00368	0.00522	CcSEcCtD
Darifenacin—Flatulence—Chenodeoxycholic acid—primary biliary cirrhosis	0.00368	0.00522	CcSEcCtD
Darifenacin—Back pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00361	0.00512	CcSEcCtD
Darifenacin—Back pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00361	0.00512	CcSEcCtD
Darifenacin—Arthralgia—Colchicine—primary biliary cirrhosis	0.00354	0.00502	CcSEcCtD
Darifenacin—Angioedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.00341	0.00484	CcSEcCtD
Darifenacin—Angioedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.00341	0.00484	CcSEcCtD
Darifenacin—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.00335	0.00475	CcSEcCtD
Darifenacin—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.00335	0.00475	CcSEcCtD
Darifenacin—Shock—Colchicine—primary biliary cirrhosis	0.00334	0.00473	CcSEcCtD
Darifenacin—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.00333	0.00472	CcSEcCtD
Darifenacin—Palpitations—Ursodeoxycholic acid—primary biliary cirrhosis	0.0033	0.00468	CcSEcCtD
Darifenacin—Palpitations—Chenodeoxycholic acid—primary biliary cirrhosis	0.0033	0.00468	CcSEcCtD
Darifenacin—Skin disorder—Colchicine—primary biliary cirrhosis	0.00329	0.00467	CcSEcCtD
Darifenacin—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00328	0.00465	CcSEcCtD
Darifenacin—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00328	0.00465	CcSEcCtD
Darifenacin—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.00326	0.00462	CcSEcCtD
Darifenacin—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.00326	0.00462	CcSEcCtD
Darifenacin—Hypertension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00322	0.00457	CcSEcCtD
Darifenacin—Hypertension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00322	0.00457	CcSEcCtD
Darifenacin—Arthralgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00318	0.00451	CcSEcCtD
Darifenacin—Arthralgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00318	0.00451	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00316	0.00448	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00316	0.00448	CcSEcCtD
Darifenacin—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.00311	0.00441	CcSEcCtD
Darifenacin—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.00311	0.00441	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.00309	0.00438	CcSEcCtD
Darifenacin—Confusional state—Ursodeoxycholic acid—primary biliary cirrhosis	0.00307	0.00436	CcSEcCtD
Darifenacin—Confusional state—Chenodeoxycholic acid—primary biliary cirrhosis	0.00307	0.00436	CcSEcCtD
Darifenacin—Oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.00305	0.00432	CcSEcCtD
Darifenacin—Oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.00305	0.00432	CcSEcCtD
Darifenacin—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00303	0.00429	CcSEcCtD
Darifenacin—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00303	0.00429	CcSEcCtD
Darifenacin—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.003	0.00425	CcSEcCtD
Darifenacin—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.003	0.00425	CcSEcCtD
Darifenacin—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00299	0.00424	CcSEcCtD
Darifenacin—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00299	0.00424	CcSEcCtD
Darifenacin—Tachycardia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00297	0.00422	CcSEcCtD
Darifenacin—Tachycardia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00297	0.00422	CcSEcCtD
Darifenacin—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00296	0.0042	CcSEcCtD
Darifenacin—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00296	0.0042	CcSEcCtD
Darifenacin—Hyperhidrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00295	0.00418	CcSEcCtD
Darifenacin—Hyperhidrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00295	0.00418	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.00293	0.00415	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00278	0.00394	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00278	0.00394	CcSEcCtD
Darifenacin—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.00277	0.00393	CcSEcCtD
Darifenacin—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00276	0.00391	CcSEcCtD
Darifenacin—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00276	0.00391	CcSEcCtD
Darifenacin—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00272	0.00385	CcSEcCtD
Darifenacin—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00272	0.00385	CcSEcCtD
Darifenacin—Somnolence—Ursodeoxycholic acid—primary biliary cirrhosis	0.00271	0.00384	CcSEcCtD
Darifenacin—Somnolence—Chenodeoxycholic acid—primary biliary cirrhosis	0.00271	0.00384	CcSEcCtD
Darifenacin—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00268	0.0038	CcSEcCtD
Darifenacin—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00268	0.0038	CcSEcCtD
Darifenacin—Abdominal pain—Colchicine—primary biliary cirrhosis	0.00268	0.0038	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00263	0.00373	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00263	0.00373	CcSEcCtD
Darifenacin—Pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00261	0.0037	CcSEcCtD
Darifenacin—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00261	0.0037	CcSEcCtD
Darifenacin—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00261	0.0037	CcSEcCtD
Darifenacin—Pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00261	0.0037	CcSEcCtD
Darifenacin—Feeling abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.00251	0.00356	CcSEcCtD
Darifenacin—Feeling abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.00251	0.00356	CcSEcCtD
Darifenacin—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.0025	0.00354	CcSEcCtD
Darifenacin—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00249	0.00353	CcSEcCtD
Darifenacin—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00249	0.00353	CcSEcCtD
Darifenacin—Asthenia—Colchicine—primary biliary cirrhosis	0.00243	0.00345	CcSEcCtD
Darifenacin—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00241	0.00342	CcSEcCtD
Darifenacin—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00241	0.00342	CcSEcCtD
Darifenacin—Diarrhoea—Colchicine—primary biliary cirrhosis	0.00232	0.00329	CcSEcCtD
Darifenacin—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.00224	0.00318	CcSEcCtD
Darifenacin—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.00224	0.00318	CcSEcCtD
Darifenacin—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00219	0.0031	CcSEcCtD
Darifenacin—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00219	0.0031	CcSEcCtD
Darifenacin—Vomiting—Colchicine—primary biliary cirrhosis	0.00216	0.00306	CcSEcCtD
Darifenacin—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.00216	0.00306	CcSEcCtD
Darifenacin—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.00216	0.00306	CcSEcCtD
Darifenacin—Rash—Colchicine—primary biliary cirrhosis	0.00214	0.00303	CcSEcCtD
Darifenacin—Dermatitis—Colchicine—primary biliary cirrhosis	0.00214	0.00303	CcSEcCtD
Darifenacin—Headache—Colchicine—primary biliary cirrhosis	0.00212	0.00301	CcSEcCtD
Darifenacin—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00208	0.00296	CcSEcCtD
Darifenacin—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00208	0.00296	CcSEcCtD
Darifenacin—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00201	0.00286	CcSEcCtD
Darifenacin—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00201	0.00286	CcSEcCtD
Darifenacin—Nausea—Colchicine—primary biliary cirrhosis	0.00201	0.00286	CcSEcCtD
Darifenacin—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.00194	0.00275	CcSEcCtD
Darifenacin—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.00194	0.00275	CcSEcCtD
Darifenacin—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.00192	0.00272	CcSEcCtD
Darifenacin—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.00192	0.00272	CcSEcCtD
Darifenacin—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00192	0.00272	CcSEcCtD
Darifenacin—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00192	0.00272	CcSEcCtD
Darifenacin—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.00191	0.00271	CcSEcCtD
Darifenacin—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.00191	0.00271	CcSEcCtD
Darifenacin—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00181	0.00257	CcSEcCtD
Darifenacin—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00181	0.00257	CcSEcCtD
Darifenacin—CHRM2—G alpha (i) signalling events—CXCR5—primary biliary cirrhosis	8.95e-05	0.00726	CbGpPWpGaD
Darifenacin—CHRM1—GPCRs, Class A Rhodopsin-like—CXCR5—primary biliary cirrhosis	8.42e-05	0.00682	CbGpPWpGaD
Darifenacin—CHRM3—GPCRs, Class A Rhodopsin-like—CXCR5—primary biliary cirrhosis	8.39e-05	0.0068	CbGpPWpGaD
Darifenacin—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR5—primary biliary cirrhosis	8.31e-05	0.00674	CbGpPWpGaD
Darifenacin—CHRM4—GPCR ligand binding—CXCR5—primary biliary cirrhosis	8.14e-05	0.0066	CbGpPWpGaD
Darifenacin—CHRM2—G alpha (i) signalling events—CXCL9—primary biliary cirrhosis	8.13e-05	0.00659	CbGpPWpGaD
Darifenacin—CHRM5—GPCR ligand binding—CXCR5—primary biliary cirrhosis	7.8e-05	0.00632	CbGpPWpGaD
Darifenacin—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	7.62e-05	0.00618	CbGpPWpGaD
Darifenacin—CHRM4—GPCR ligand binding—CXCL9—primary biliary cirrhosis	7.39e-05	0.006	CbGpPWpGaD
Darifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	7.21e-05	0.00585	CbGpPWpGaD
Darifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	7.19e-05	0.00583	CbGpPWpGaD
Darifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	7.12e-05	0.00577	CbGpPWpGaD
Darifenacin—CHRM5—GPCR ligand binding—CXCL9—primary biliary cirrhosis	7.08e-05	0.00574	CbGpPWpGaD
Darifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	6.55e-05	0.00531	CbGpPWpGaD
Darifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	6.53e-05	0.00529	CbGpPWpGaD
Darifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	6.46e-05	0.00524	CbGpPWpGaD
Darifenacin—CHRM4—G alpha (i) signalling events—CXCL10—primary biliary cirrhosis	6.36e-05	0.00516	CbGpPWpGaD
Darifenacin—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—primary biliary cirrhosis	5.97e-05	0.00484	CbGpPWpGaD
Darifenacin—CYP2D6—Melatonin metabolism and effects—NFKB1—primary biliary cirrhosis	5.72e-05	0.00464	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—CXCR5—primary biliary cirrhosis	5.49e-05	0.00445	CbGpPWpGaD
Darifenacin—CHRM4—G alpha (i) signalling events—CCL5—primary biliary cirrhosis	5.48e-05	0.00444	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—CXCR5—primary biliary cirrhosis	5.47e-05	0.00444	CbGpPWpGaD
Darifenacin—CHRM2—SIDS Susceptibility Pathways—PPARGC1A—primary biliary cirrhosis	5.43e-05	0.00441	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—CXCR5—primary biliary cirrhosis	5.42e-05	0.00439	CbGpPWpGaD
Darifenacin—CHRM5—G alpha (q) signalling events—AGT—primary biliary cirrhosis	5.27e-05	0.00427	CbGpPWpGaD
Darifenacin—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	5.06e-05	0.0041	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—CXCL9—primary biliary cirrhosis	4.99e-05	0.00404	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—CXCL9—primary biliary cirrhosis	4.97e-05	0.00403	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—CXCL9—primary biliary cirrhosis	4.92e-05	0.00399	CbGpPWpGaD
Darifenacin—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	4.84e-05	0.00393	CbGpPWpGaD
Darifenacin—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—primary biliary cirrhosis	4.71e-05	0.00382	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	4.6e-05	0.00373	CbGpPWpGaD
Darifenacin—CHRM4—G alpha (i) signalling events—AGT—primary biliary cirrhosis	4.58e-05	0.00371	CbGpPWpGaD
Darifenacin—CHRM1—Circadian rythm related genes—PPARGC1A—primary biliary cirrhosis	4.49e-05	0.00364	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	4.41e-05	0.00357	CbGpPWpGaD
Darifenacin—CHRM4—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	4.35e-05	0.00353	CbGpPWpGaD
Darifenacin—CHRM2—SIDS Susceptibility Pathways—HIF1A—primary biliary cirrhosis	4.25e-05	0.00344	CbGpPWpGaD
Darifenacin—CHRM2—G alpha (i) signalling events—CXCL10—primary biliary cirrhosis	4.23e-05	0.00343	CbGpPWpGaD
Darifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—primary biliary cirrhosis	4.2e-05	0.00341	CbGpPWpGaD
Darifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—primary biliary cirrhosis	4.19e-05	0.0034	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—CXCR5—primary biliary cirrhosis	4.18e-05	0.00339	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	4.18e-05	0.00339	CbGpPWpGaD
Darifenacin—CHRM5—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	4.17e-05	0.00338	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—CXCR5—primary biliary cirrhosis	4e-05	0.00324	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	4e-05	0.00324	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—LBR—primary biliary cirrhosis	3.92e-05	0.00318	CbGpPWpGaD
Darifenacin—CHRM4—GPCR ligand binding—CXCL10—primary biliary cirrhosis	3.85e-05	0.00312	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—CXCL9—primary biliary cirrhosis	3.79e-05	0.00308	CbGpPWpGaD
Darifenacin—CHRM1—G alpha (q) signalling events—AGT—primary biliary cirrhosis	3.71e-05	0.00301	CbGpPWpGaD
Darifenacin—CHRM3—G alpha (q) signalling events—AGT—primary biliary cirrhosis	3.7e-05	0.003	CbGpPWpGaD
Darifenacin—CHRM5—GPCR ligand binding—CXCL10—primary biliary cirrhosis	3.69e-05	0.00299	CbGpPWpGaD
Darifenacin—CHRM2—G alpha (i) signalling events—CCL5—primary biliary cirrhosis	3.64e-05	0.00296	CbGpPWpGaD
Darifenacin—CHRM4—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	3.64e-05	0.00295	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—CXCL9—primary biliary cirrhosis	3.63e-05	0.00295	CbGpPWpGaD
Darifenacin—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—primary biliary cirrhosis	3.52e-05	0.00286	CbGpPWpGaD
Darifenacin—CHRM5—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	3.49e-05	0.00283	CbGpPWpGaD
Darifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	3.41e-05	0.00277	CbGpPWpGaD
Darifenacin—CYP2D6—Biological oxidations—GGT1—primary biliary cirrhosis	3.41e-05	0.00276	CbGpPWpGaD
Darifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	3.4e-05	0.00276	CbGpPWpGaD
Darifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	3.37e-05	0.00273	CbGpPWpGaD
Darifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—primary biliary cirrhosis	3.32e-05	0.00269	CbGpPWpGaD
Darifenacin—CHRM4—GPCR ligand binding—CCL5—primary biliary cirrhosis	3.32e-05	0.00269	CbGpPWpGaD
Darifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—primary biliary cirrhosis	3.31e-05	0.00268	CbGpPWpGaD
Darifenacin—CHRM1—Circadian rythm related genes—NOS2—primary biliary cirrhosis	3.2e-05	0.00259	CbGpPWpGaD
Darifenacin—CHRM5—GPCR ligand binding—CCL5—primary biliary cirrhosis	3.17e-05	0.00257	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	3.1e-05	0.00252	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	3.09e-05	0.00251	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	3.06e-05	0.00248	CbGpPWpGaD
Darifenacin—CHRM2—G alpha (i) signalling events—AGT—primary biliary cirrhosis	3.05e-05	0.00247	CbGpPWpGaD
Darifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	2.94e-05	0.00238	CbGpPWpGaD
Darifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	2.93e-05	0.00237	CbGpPWpGaD
Darifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	2.9e-05	0.00235	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—OGDH—primary biliary cirrhosis	2.84e-05	0.0023	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CXCR5—primary biliary cirrhosis	2.82e-05	0.00228	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	2.82e-05	0.00228	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CXCR5—primary biliary cirrhosis	2.81e-05	0.00228	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	2.81e-05	0.00228	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CXCR5—primary biliary cirrhosis	2.78e-05	0.00226	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	2.78e-05	0.00226	CbGpPWpGaD
Darifenacin—CHRM4—GPCR ligand binding—AGT—primary biliary cirrhosis	2.77e-05	0.00225	CbGpPWpGaD
Darifenacin—CHRM5—GPCR ligand binding—AGT—primary biliary cirrhosis	2.66e-05	0.00215	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—CXCL10—primary biliary cirrhosis	2.6e-05	0.00211	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—CXCL10—primary biliary cirrhosis	2.59e-05	0.0021	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CDH5—primary biliary cirrhosis	2.56e-05	0.00208	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—CXCL10—primary biliary cirrhosis	2.56e-05	0.00208	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CXCL9—primary biliary cirrhosis	2.56e-05	0.00207	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CXCL9—primary biliary cirrhosis	2.55e-05	0.00207	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PDHX—primary biliary cirrhosis	2.53e-05	0.00205	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CXCL9—primary biliary cirrhosis	2.53e-05	0.00205	CbGpPWpGaD
Darifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—primary biliary cirrhosis	2.48e-05	0.00201	CbGpPWpGaD
Darifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—primary biliary cirrhosis	2.47e-05	0.002	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CXCR5—primary biliary cirrhosis	2.47e-05	0.002	CbGpPWpGaD
Darifenacin—CHRM2—SIDS Susceptibility Pathways—NFKB1—primary biliary cirrhosis	2.47e-05	0.002	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CDH5—primary biliary cirrhosis	2.46e-05	0.00199	CbGpPWpGaD
Darifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	2.46e-05	0.00199	CbGpPWpGaD
Darifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	2.45e-05	0.00198	CbGpPWpGaD
Darifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	2.42e-05	0.00197	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—ABCB4—primary biliary cirrhosis	2.38e-05	0.00193	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—DLAT—primary biliary cirrhosis	2.38e-05	0.00193	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CXCR5—primary biliary cirrhosis	2.36e-05	0.00192	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—LBR—primary biliary cirrhosis	2.35e-05	0.0019	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CXCL9—primary biliary cirrhosis	2.24e-05	0.00182	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—CCL5—primary biliary cirrhosis	2.24e-05	0.00181	CbGpPWpGaD
Darifenacin—CYP3A4—Biological oxidations—GGT1—primary biliary cirrhosis	2.23e-05	0.00181	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—CCL5—primary biliary cirrhosis	2.23e-05	0.00181	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—CCL5—primary biliary cirrhosis	2.21e-05	0.00179	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	2.18e-05	0.00176	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CXCL9—primary biliary cirrhosis	2.15e-05	0.00174	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	2.08e-05	0.00169	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—ELMO1—primary biliary cirrhosis	2.07e-05	0.00168	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—ELMO1—primary biliary cirrhosis	1.99e-05	0.00161	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—CXCL10—primary biliary cirrhosis	1.98e-05	0.0016	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—CXCL10—primary biliary cirrhosis	1.89e-05	0.00153	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—CCL5—primary biliary cirrhosis	1.87e-05	0.00152	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—AGT—primary biliary cirrhosis	1.87e-05	0.00152	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—AGT—primary biliary cirrhosis	1.86e-05	0.00151	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—AGT—primary biliary cirrhosis	1.85e-05	0.0015	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—MMP3—primary biliary cirrhosis	1.8e-05	0.00146	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—CCL5—primary biliary cirrhosis	1.79e-05	0.00145	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CDH5—primary biliary cirrhosis	1.73e-05	0.0014	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—MMP3—primary biliary cirrhosis	1.73e-05	0.0014	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CDH5—primary biliary cirrhosis	1.72e-05	0.0014	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CDH5—primary biliary cirrhosis	1.71e-05	0.00138	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—CCL5—primary biliary cirrhosis	1.7e-05	0.00138	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—OGDH—primary biliary cirrhosis	1.7e-05	0.00138	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CXCR5—primary biliary cirrhosis	1.66e-05	0.00135	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CXCR5—primary biliary cirrhosis	1.66e-05	0.00135	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CXCR5—primary biliary cirrhosis	1.64e-05	0.00133	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—CCL5—primary biliary cirrhosis	1.63e-05	0.00132	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—AGT—primary biliary cirrhosis	1.57e-05	0.00127	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—LBR—primary biliary cirrhosis	1.53e-05	0.00124	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PDHX—primary biliary cirrhosis	1.51e-05	0.00123	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CXCL9—primary biliary cirrhosis	1.51e-05	0.00123	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CXCL9—primary biliary cirrhosis	1.51e-05	0.00122	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—AGT—primary biliary cirrhosis	1.5e-05	0.00122	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CXCL9—primary biliary cirrhosis	1.49e-05	0.00121	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	1.47e-05	0.00119	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	1.46e-05	0.00119	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	1.45e-05	0.00117	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—NUP210—primary biliary cirrhosis	1.43e-05	0.00116	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—AGT—primary biliary cirrhosis	1.42e-05	0.00115	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ABCB4—primary biliary cirrhosis	1.42e-05	0.00115	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—DLAT—primary biliary cirrhosis	1.42e-05	0.00115	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—ELMO1—primary biliary cirrhosis	1.4e-05	0.00113	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—ELMO1—primary biliary cirrhosis	1.39e-05	0.00113	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—ELMO1—primary biliary cirrhosis	1.38e-05	0.00112	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—AGT—primary biliary cirrhosis	1.36e-05	0.00111	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CXCL10—primary biliary cirrhosis	1.33e-05	0.00108	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CXCL10—primary biliary cirrhosis	1.33e-05	0.00108	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—ABCG2—primary biliary cirrhosis	1.33e-05	0.00108	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CXCL10—primary biliary cirrhosis	1.32e-05	0.00107	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—CCL5—primary biliary cirrhosis	1.26e-05	0.00102	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—CCL5—primary biliary cirrhosis	1.26e-05	0.00102	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—CCL5—primary biliary cirrhosis	1.25e-05	0.00101	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—MMP3—primary biliary cirrhosis	1.22e-05	0.000986	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—MMP3—primary biliary cirrhosis	1.21e-05	0.000982	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—MMP3—primary biliary cirrhosis	1.2e-05	0.000973	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CXCL10—primary biliary cirrhosis	1.17e-05	0.000947	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CCL5—primary biliary cirrhosis	1.15e-05	0.00093	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CCL5—primary biliary cirrhosis	1.14e-05	0.000927	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—CTGF—primary biliary cirrhosis	1.14e-05	0.000924	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CCL5—primary biliary cirrhosis	1.13e-05	0.000918	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—GOT2—primary biliary cirrhosis	1.13e-05	0.000916	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CXCL10—primary biliary cirrhosis	1.12e-05	0.000907	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—OGDH—primary biliary cirrhosis	1.11e-05	0.000899	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—MMP3—primary biliary cirrhosis	1.06e-05	0.000864	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—TYK2—primary biliary cirrhosis	1.06e-05	0.000863	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—AGT—primary biliary cirrhosis	1.06e-05	0.000857	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—AGT—primary biliary cirrhosis	1.05e-05	0.000854	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—AGT—primary biliary cirrhosis	1.04e-05	0.000846	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MMP3—primary biliary cirrhosis	1.02e-05	0.000827	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—TYK2—primary biliary cirrhosis	1.02e-05	0.000826	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CCL5—primary biliary cirrhosis	1e-05	0.000815	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PDHX—primary biliary cirrhosis	9.88e-06	0.000802	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—GGT1—primary biliary cirrhosis	9.75e-06	0.000791	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—GOT1—primary biliary cirrhosis	9.75e-06	0.000791	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	9.74e-06	0.00079	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CCL5—primary biliary cirrhosis	9.62e-06	0.00078	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—AGT—primary biliary cirrhosis	9.6e-06	0.000778	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—AGT—primary biliary cirrhosis	9.57e-06	0.000776	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—AGT—primary biliary cirrhosis	9.47e-06	0.000768	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	9.33e-06	0.000756	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—DLAT—primary biliary cirrhosis	9.29e-06	0.000754	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ABCB4—primary biliary cirrhosis	9.29e-06	0.000754	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PPARGC1A—primary biliary cirrhosis	8.68e-06	0.000704	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—NUP210—primary biliary cirrhosis	8.54e-06	0.000693	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—HIF1A—primary biliary cirrhosis	8.44e-06	0.000684	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—AGT—primary biliary cirrhosis	8.41e-06	0.000682	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—HIF1A—primary biliary cirrhosis	8.08e-06	0.000655	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—AGT—primary biliary cirrhosis	8.05e-06	0.000653	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ABCG2—primary biliary cirrhosis	7.94e-06	0.000644	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CXCL10—primary biliary cirrhosis	7.87e-06	0.000638	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CXCL10—primary biliary cirrhosis	7.85e-06	0.000636	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CXCL10—primary biliary cirrhosis	7.77e-06	0.00063	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CD80—primary biliary cirrhosis	7.45e-06	0.000604	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MMP3—primary biliary cirrhosis	7.18e-06	0.000582	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—TYK2—primary biliary cirrhosis	7.18e-06	0.000582	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MMP3—primary biliary cirrhosis	7.16e-06	0.00058	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—TYK2—primary biliary cirrhosis	7.15e-06	0.00058	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CD80—primary biliary cirrhosis	7.13e-06	0.000578	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MMP3—primary biliary cirrhosis	7.09e-06	0.000575	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—TYK2—primary biliary cirrhosis	7.08e-06	0.000574	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CTGF—primary biliary cirrhosis	6.81e-06	0.000553	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CCL5—primary biliary cirrhosis	6.78e-06	0.00055	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—AGT—primary biliary cirrhosis	6.76e-06	0.000548	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CCL5—primary biliary cirrhosis	6.75e-06	0.000548	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GOT2—primary biliary cirrhosis	6.75e-06	0.000548	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CCL5—primary biliary cirrhosis	6.69e-06	0.000542	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	6.57e-06	0.000533	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	6.55e-06	0.000531	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	6.48e-06	0.000526	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—TYK2—primary biliary cirrhosis	6.29e-06	0.00051	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—TYK2—primary biliary cirrhosis	6.02e-06	0.000488	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GGT1—primary biliary cirrhosis	5.83e-06	0.000473	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GOT1—primary biliary cirrhosis	5.83e-06	0.000473	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—HIF1A—primary biliary cirrhosis	5.69e-06	0.000461	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—HIF1A—primary biliary cirrhosis	5.67e-06	0.00046	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—AGT—primary biliary cirrhosis	5.67e-06	0.00046	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—AGT—primary biliary cirrhosis	5.65e-06	0.000458	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—HIF1A—primary biliary cirrhosis	5.62e-06	0.000455	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—AGT—primary biliary cirrhosis	5.6e-06	0.000454	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—NUP210—primary biliary cirrhosis	5.59e-06	0.000453	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ABCG2—primary biliary cirrhosis	5.19e-06	0.000421	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PPARGC1A—primary biliary cirrhosis	5.19e-06	0.000421	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—ALB—primary biliary cirrhosis	5.19e-06	0.000421	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CD80—primary biliary cirrhosis	5.02e-06	0.000407	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CD80—primary biliary cirrhosis	5.01e-06	0.000406	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CD80—primary biliary cirrhosis	4.96e-06	0.000402	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—MMP9—primary biliary cirrhosis	4.95e-06	0.000402	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—NFKB1—primary biliary cirrhosis	4.9e-06	0.000397	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MMP9—primary biliary cirrhosis	4.74e-06	0.000384	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—NFKB1—primary biliary cirrhosis	4.69e-06	0.00038	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CTGF—primary biliary cirrhosis	4.46e-06	0.000361	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GOT2—primary biliary cirrhosis	4.42e-06	0.000358	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—TYK2—primary biliary cirrhosis	4.24e-06	0.000344	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—TYK2—primary biliary cirrhosis	4.23e-06	0.000343	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—TYK2—primary biliary cirrhosis	4.18e-06	0.000339	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—AGT—primary biliary cirrhosis	4.04e-06	0.000328	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GGT1—primary biliary cirrhosis	3.81e-06	0.000309	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GOT1—primary biliary cirrhosis	3.81e-06	0.000309	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PPARGC1A—primary biliary cirrhosis	3.39e-06	0.000275	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MMP9—primary biliary cirrhosis	3.34e-06	0.000271	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MMP9—primary biliary cirrhosis	3.33e-06	0.00027	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—NFKB1—primary biliary cirrhosis	3.3e-06	0.000268	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MMP9—primary biliary cirrhosis	3.3e-06	0.000267	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—NFKB1—primary biliary cirrhosis	3.29e-06	0.000267	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—NFKB1—primary biliary cirrhosis	3.26e-06	0.000264	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ALB—primary biliary cirrhosis	3.1e-06	0.000251	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—AGT—primary biliary cirrhosis	2.64e-06	0.000214	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ALB—primary biliary cirrhosis	2.03e-06	0.000164	CbGpPWpGaD
